Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1,594.05 million compared to CNY 1,118.85 million a year ago. Net income was CNY 327.87 million compared to CNY 190.8 million a year ago.

Basic earnings per share from continuing operations was CNY 0.3135 compared to CNY 0.1824 a year ago. Diluted earnings per share from continuing operations was CNY 0.3135 compared to CNY 0.1824 a year ago.